Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Gastroenterology

Journal Scan / Research · January 29, 2024

Efficacy and Safety of Cenicriviroc for the Treatment of Liver Fibrosis in Patients With NASH

Clinical Gastroenterology and Hepatology

 

Additional Info

Clinical Gastroenterology and Hepatology
Cenicriviroc Lacked Efficacy to Treat Liver Fibrosis in Nonalcoholic Steatohepatitis: AURORA Phase III Randomized Study
Clin. Gastroenterol. Hepatol. 2024 Jan 01;22(1)124-134.e1, QM Anstee, BA Neuschwander-Tetri, V Wai-Sun Wong, MF Abdelmalek, G Rodriguez-Araujo, H Landgren, GS Park, P Bedossa, N Alkhouri, F Tacke, AJ Sanyal

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading